Quintessence Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2000-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://quintbio.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of QBI-139 in Subjects With Advanced Solid Tumors
Phase 1
- Conditions
- Solid Tumors
- First Posted Date
- 2009-01-08
- Last Posted Date
- 2015-01-28
- Lead Sponsor
- Quintessence Biosciences, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00818831
- Locations
- 🇺🇸
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
🇺🇸University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States
News
No news found